Biological functions of kojic acid and its derivatives in medicine, cosmetics, and food industry: Insights into health aspects

被引:26
作者
Brtko, Julius [1 ]
机构
[1] Slovak Acad Sci, Inst Expt Endocrinol, Dept Endocrine Regulat & Psychopharmacol, Biomed Res Ctr, Dubravska Cesta 9, Bratislava 84505, Slovakia
关键词
5-hydroxy-2-(hydroxymethyl)-4H-pyran-4-one; antiproliferative; health; kojic acid derivatives; tyrosinase inhibitor; ANTIFUNGAL ACTIVITY; GROWTH-INHIBITION; ESCHERICHIA-COLI; ASPERGILLUS; ANTICONVULSANT; AGENTS; 4H-PYRAN-4-ONE; DESIGN; AMIDE;
D O I
10.1002/ardp.202200215
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
This review traces the road leading to the demonstration of a variety of kojic acid chemical and biological properties. It illustrates the biological effects of several synthetic kojic acid derivatives. Besides the main capability of kojic acid to inhibit the activity of tyrosinase in melanin synthesis, the focus is also on antibacterial, antifungal, antiproliferative, anti-inflammatory, and other biological activities of kojic acid derivatives, which may be applicable in medicine. Kojic acid derivatives manifest antiparasitic effects and its metal complexes may serve as potential radioprotective agents. Several kojic acid derivatives exert antidiabetic therapeutic potential as nuclear peroxisome proliferator-activated receptor alpha/gamma dual agonists. Kojic acid derivatives show pancreatic lipase inhibitor properties and some of its derivatives are cognate ligands for the histamine H-3 receptor. Recently, "KojoTacrines" were reported as novel perspective preparations for the therapy of Alzheimer's disease. Kojic acid derivatives possess insecticidal or pesticidal activity, and they are powerful chelators, able to form iron(III) containing nanocomposites, as well. Toxicology and health aspects of products containing kojic acid produced by the cosmetic, health care, or food industry are summarized. Kojic acid thus represents a highly attractive molecule containing a skeleton that allows the synthesis of new kojic acid derivatives to create a novel class of effective and specific pharmaceutical preparations.
引用
收藏
页数:7
相关论文
共 103 条
[31]  
Dobias J., 1988, Sadlon (Czechoslovakian Patent, Patent No. 251532
[32]  
EFSA Scientific Committee on Consumer Safety, 2012, SCCS148112 EFSA
[33]  
EFSA Scientific Committee on Consumer Safety, 2008, SCCS118208 EFSA
[34]   Kojic acid repurposing as a pancreatic lipase inhibitor and the optimization of its production from a localAspergillus oryzaesoil isolate [J].
El-Korany, Sarah Mohamed ;
Helmy, Omneya Mohamed ;
El-Halawany, Ali Mahmoud ;
Ragab, Yasser El-Mohammadi ;
Zedan, Hamdallah Hafez .
BMC BIOTECHNOLOGY, 2020, 20 (01)
[35]   Kojic acid and its manganese and zinc complexes as potential radioprotective agents [J].
Emami, Saeed ;
Hosseinimehr, Seyed Jalal ;
Taghdisi, Seyed Mohammad ;
Akhlaghpoor, Shahram .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (01) :45-48
[36]   An allomaltol derivative triggers distinct death pathways in luminal a and triple-negative breast cancer subtypes [J].
Ercan, A. ;
Oncul, S. ;
Karakaya, G. ;
Aytemir, M. .
BIOORGANIC CHEMISTRY, 2020, 105
[37]  
Eyong K.O., 2012, J CHEM-NY, V5, P477
[38]   In vitro antiproliferative and cytotoxic activities of novel kojic acid derivatives:: 5-benzyloxy-2-selenocyanatomethyl- and 5-methoxy-2-selenocyanatomethyl-4-pyranone [J].
Fickova, Maria ;
Pravdova, Eliska ;
Rondhal, Lars ;
Uher, Michal ;
Brtko, Julius .
JOURNAL OF APPLIED TOXICOLOGY, 2008, 28 (04) :554-559
[39]   Changes in thyroid function during development of thyroid hyperplasia induced by kojic acid in F344 rats [J].
Fujimoto, N ;
Onodera, H ;
Mitsumori, K ;
Tamura, T ;
Maruyama, S ;
Ito, A .
CARCINOGENESIS, 1999, 20 (08) :1567-1571
[40]   Induction of thyroid tumours in (C57BL/6NxC3H/N)F1 mice by oral administration of kojic acid [J].
Fujimoto, N ;
Watanabe, H ;
Nakatani, T ;
Roy, G ;
Ito, A .
FOOD AND CHEMICAL TOXICOLOGY, 1998, 36 (08) :697-703